Featured Articles
(Reuters) July 26, 2017 - A lawyer for Johnson & Johnson on Wednesday urged jurors to not find it liable in the first trial the company has faced in California over claims that its talc-based products for feminine hygiene can cause ovarian cancer.
Read Article
(Yahoo! Finance) July 27, 2017 - TESARO, Inc. and Takeda Pharmaceutical Company Limited today announced an exclusive licensing agreement for the commercialization and clinical development of niraparib, a novel poly ADP-ribose polymerase (PARP) inhibitor.
Read Article
Latest Articles
July 25, 2017
July 20, 2017
July 19, 2017
July 18, 2017
July 18, 2017
July 17, 2017
July 17, 2017
July 13, 2017
View More
News Commentary
There is no Ovarian commentary.

OBR Green
There are no Ovarian OBR Green articles.
Featured Videos
There are no videos.
OBR Blog
There are no Ovarian blog entries.